• Resumen
  • Sinónimos
  • Signos y Síntomas
  • Causas y Herencia
  • Frecuencia
  • Enfermedades con síntomas similares
  • Diagnóstico
  • Tratamiento
  • Investigaciones
  • Referencias
  • Programas & Recursos
  • Informe completo

Fontaine Progeroid Syndrome

Imprimir

Última actualización: 4/8/2025
Años publicados: 1996, 2003, 2025


Reconocimiento

NORD gratefully acknowledges Gioconda Alyea, MD (FMG), MS, National Organization for Rare Disorders, for assistance in the preparation of this report.


Advertisement

Resumen

Summary
Fontaine progeroid syndrome is a very rare condition that affects many parts of the body. It can cause poor growth, changes in the shape of the bones and face, and skin that is thin, sagging, and appears older than normal (progeroid appearance). This aged appearance is most noticeable in babies and young children but tends to improve as they grow older. 1

People with Fontaine progeroid syndrome may have specific features like a short, round head shape, large soft spots on the skull, and abnormalities in the tips of the fingers. Other problems may include heart issues, differences in urinary or reproductive organs, eye problems, or stomach and digestive system issues.1

This condition is caused by changes (disease-causing variants) in the SLC25A24 gene. These gene variants occur randomly in most cases, meaning that in most people the condition is not inherited from parents.

There is no cure for Fontaine progeroid syndrome, but many of the symptoms can be treated or managed. 1

Introduction

Fontaine progeroid syndrome was previously described under other names such as “Gorlin-Chaudhry-Moss syndrome”, “Fontaine-Farriaux syndrome” and “Petty syndrome”. Doctors now know that these conditions share the same underlying genetic cause and are all part of “SLC25A24 Fontaine progeroid syndrome” or Fontaine progeroid syndrome. 1,2

  • Sección siguiente >
  • < Sección anterior
  • Sección siguiente >

Sinónimos

  • craniofacial dysostosis-genital, dental, cardiac anomalies syndrome
  • craniofacial dysostosis, hypertrichosis, hypoplasia of labia majora, dental and eye anomalies, patent ductus arteriosus, and normal intelligence
  • FPS
  • Gorlin Chaudhry Moss syndrome
  • GCM syndrome
  • Petty syndrome
  • Petty-Laxova-Wiedemann syndrome
  • progeroid syndrome congenital Petty type
  • progeroid syndrome Petty type
  • < Sección anterior
  • Sección siguiente >
  • < Sección anterior
  • Sección siguiente >

Signos y Síntomas

Fontaine progeroid syndrome is characterized by an abnormal skull shape, distinctive face and an appearance of premature aging that is sometime described as progeroid. The signs and symptoms of Fontaine progeroid syndrome may include: 1,2,3,4,5,6,7,8

  • Growth problems that can start before birth (intrauterine growth restriction) and continue after birth
  • Feeding difficulties where babies struggle with feeding and may require extra nutritional support to ensure proper growth and weight gain
  • Abnormal shape of the skull due to a premature fusion of certain skull bones (craniosynostosis), particularly along the coronal suture, the growth line stretching from ear to ear over the top of the head
    • The head may appear unusually wide and short with a pointed top due to the abnormal skull development (acrobrachycephaly)
  • Slow hardening (ossification) of the skull bones, leaving a large, persistent anterior fontanelle (soft spot on the head) and that sometimes coexists with craniosynostosis, leading to uneven skull development
  • Distinctive facial features that may include:
    • Middle part of the face appears flat or sunken due to underdevelopment of the facial bones (mid face hypoplasia)
    • Small eyes (microphthalmia)
    • Narrowed palpebral fissures where the openings of the eyes (eyelid slits) may be shorter or slanted
    • Flat nasal bridge where the bridge of the nose is often broad and low
    • Small, low-set ears
    • Thin, translucent skin on the face that results in an aged appearance
  • Skin problems that make the affected people look older than their actual age which is described as “progeroid” (resembling premature aging)
    • Lipodystrophy, a marked loss of fatty tissue beneath the skin, especially in the face and limbs which leads to a thin, gaunt appearance
    • Thin, wrinkled and sagging skin where the skin may feel loose and appear excessively wrinkled, especially in infants (over time, the skin may improve but often remains thinner than normal)
  • Hair abnormalities that may include:
    • Sparse scalp hair where babies often have thin or sparse hair on the scalp, paired with low hairlines at the front and back of the head
    • Coarse hair texture develops as children grow, with irregular patterns, such as multiple hair whorls (circular patterns in the hair’s growth)
    • Excessive hair growth (hypertrichosis), common on the face, back, arms and legs
  • Abnormalities of the limbs, fingers, toes and nails
    • Shortness of the bones at the tips of the fingers and toes (distal phalanges) giving the fingers and toes a stubby appearance
    • Webbing (syndactyly) between the fingers or toes
    • Underdeveloped or missing nails where nails may be unusually small, poorly developed, or entirely absent
  • Dental abnormalities such as:
    • Teeth may be smaller than average (microdontia)
    • Missing teeth
  • Heart and vascular defects that are present at birth (congenital heart defects) including:
    • Holes between the heart’s chambers (e.g., atrial septal defect or ventricular septal defect)
    • Increased blood pressure in the arteries of the lungs may occur, leading to strain on the heart (pulmonary hypertension)
    • Enlargement of the aorta, the main artery that carries blood from the heart to the rest of the body (aortic dilation), increasing the risk of heart complications
  • Umbilical hernias, which are bulges near the belly button and may result from weak or underdeveloped abdominal muscles
  • Underdeveloped external genital folds (hypoplasia of the labia majora)
  • Mild developmental delay that may include:
    • Mild delays in reaching motor milestones like sitting or walking
      • However, most children eventually catch up, and intelligence is typically within the normal range
  • Vision problems that can include:
    • Farsightedness (hyperopia) which is common, making close-up vision blurry
    • Small eyes (microphthalmia) that may also contribute to visual impairments
  • Hearing loss, which can vary in severity.

 

  • < Sección anterior
  • Sección siguiente >
  • < Sección anterior
  • Sección siguiente >

Causas y Herencia

Fontaine progeroid syndrome is mainly caused by changes (disease-causing variants or pathogenic variants) in the SLC25A24 gene. This gene provides instructions for making a protein that helps transport important molecules, including ATP (the body’s main energy source), across the inner membrane of mitochondria. Mitochondria are like tiny power plants inside cells, responsible for producing energy and supporting essential cell functions, like building proteins and breaking down molecules for the body to use.1,8

SLC25A24 gene variants change the structure of the protein, making it less effective at transporting molecules across the mitochondrial membrane. This leads to several problems:1,6,8

  • Mitochondria swell and grow larger than normal
  • Mitochondria break apart into smaller pieces
  • Energy production decreases, leaving cells with less fuel to function properly
  • Cell death increases because of the lack of energy and damaged mitochondria

These energy problems and increased cell death are likely responsible for many of the signs and symptoms of Fontaine progeroid syndrome, like abnormal growth and connective tissue issues, though scientists are still working to understand the exact link between these changes and the specific symptoms people experience.

In some people with the syndrome, no variants in the SLC25A24 gene are found, suggesting that variants in other, still unknown genes may also cause the condition.

Fontaine progeroid syndrome is inherited in an autosomal dominant pattern. Dominant genetic disorders occur when only a single copy of a disease-causing gene variant is necessary to cause the disease. This means only one variant copy of the SLC25A24 gene is enough to cause the condition. The gene variant can be inherited from either parent or can be the result of a new (de novo) changed gene in the affected individual that is not inherited. The risk of passing the gene variant from an affected parent to a child is 50% for each pregnancy. The risk is the same for males and females.

In most cases of Fontaine progeroid syndrome, the variant is de novo, meaning it happens for the first time in the child and wasn’t inherited from the parents. When a variant is de novo, the chance of having another child with the same syndrome is generally very low.

However, there is a small chance (~1%) for the condition to be transmitted to a child if one of the parents has germline mosaicism, a rare situation where some of one parent’s reproductive cells carry the variant, even though the rest of their body cells do not. Because of this small possibility, genetic counseling and options like prenatal or pre-implantation genetic testing may be offered to families who are considering having more children.1

  • < Sección anterior
  • Sección siguiente >
  • < Sección anterior
  • Sección siguiente >

Frecuencia

Fontaine progeroid syndrome is extremely rare, with an estimated prevalence of less than 1 in 1,000,000.7As of 2024, only 13 individuals worldwide have been confirmed to have Fontaine progeroid syndrome through genetic testing.

  • < Sección anterior
  • Sección siguiente >
  • < Sección anterior
  • Sección siguiente >

Diagnóstico

Doctors suspect the diagnosis based on the signs and symptoms mentioned above, such as growth problems, skin problems, facial features, skull shape, hair patterns, hernia, finger and toe differences and abnormal genitalia.

Genetic testing identifying a variant in the SLC25A24 gene confirms the diagnosis 1

  • < Sección anterior
  • Sección siguiente >
  • < Sección anterior
  • Sección siguiente >

Tratamiento

Treatment

There is no cure for Fontaine progeroid syndrome but many of the symptoms can be treated or managed. Affected people may need to be treated by a team of multiple specialists including a craniofacial clinic (involving plastic surgery, neurosurgery and otolaryngology), cardiology, pulmonology, gastroenterology and clinical genetics.

While there are no official guidelines for treating this condition, doctors recommend personalized care based on a person’s symptoms and needs.

After a diagnosis is made, the following evaluations are suggested to evaluate all the problems that the affected person may have:1

  • A heart specialist (cardiologist) to check for high blood pressure in the lungs, enlarged blood vessels (aortic dilatation), or risks of tears (dissection)
  • X-rays or CT scans to check for skull or bone issues, including delayed skull formation and abnormal bones in the spine or fingers
  • An eye doctor (ophthalmologist) to evaluate vision, eyelids and other eye structures
  • A feeding team or gastroenterologist to check for swallowing difficulties or poor weight gain and special feeding methods, such as feeding tubes, may be considered
  • Regular dental checkups to help monitor for missing or small teeth and misalignment
  • A hearing test to detect any hearing loss
  • A urological evaluation in boys to check for undescended testicles (cryptorchidism) or other genital issues
  • A brain MRI might be suggested for structural brain differences and regular assessments can track motor skills, speech and learning needs
  • A genetic specialist who can help families understand the condition, risks for future pregnancies and available resources

Families may benefit from social work, parent support groups, or home nursing services.

Management and treatment are focused on relieving symptoms and improving quality of life.

Affected people need to be consulted and followed by several specialists who should work together as a team for the best management.

  • A craniofacial team may help with skull surgery if needed. Protective helmets are sometimes recommended for babies with delayed skull formation.
  • A cardiologist can evaluate the need for surgery when there are heart defects that need to be corrected.
  • A pneumologist can manage specific lung issues with treatments like oxygen therapy, managing sleep problems, or addressing aspirations (inhalation of food or liquids).
  • Ear tubes or hearing aids may be recommended for those with chronic ear infections or hearing loss.
  • Surgery may be needed for an umbilical hernia that does not heal on its own.
  • Early therapy, such as physical or speech therapy, can help children reach milestones. Schools can provide individualized education plans (IEPs) tailored to their needs.
  • Therapists can help with feeding techniques or recommend, as commented before, the need to use feeding tubes if swallowing is unsafe.1

Regular checkups are important to monitor health and catch any new issues early. Height, weight and head size should be measured at every visit. Echocardiograms are recommended at least every three years or more often if problems are found. Annual hearing and eye checkups are recommended. Progress in motor skills, learning and language should be assessed regularly.

It is recommended to avoid contact sports or any activities that may harm the skull or aorta (a major blood vessel) should be avoided. Heavy lifting or straining may increase the risk of complications, especially if the aorta is enlarged.

Aerobic exercise, such as walking or swimming, is encouraged if there are no restrictions from a doctor.

Families may benefit from connecting with parent support groups or online communities, as well as working with a social worker for additional help with caregiving or accessing resources.

  • < Sección anterior
  • Sección siguiente >
  • < Sección anterior
  • Sección siguiente >

Investigaciones

Information on current clinical trials is posted on the Internet at https://clinicaltrials.gov/ All studies receiving U.S. Government funding, and some supported by private industry, are posted on this government web site.

For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:

Tollfree: (800) 411-1222
TTY: (866) 411-1010
Email: [email protected]

Some current clinical trials also are posted on the following page on the NORD website:
https://rarediseases.org/living-with-a-rare-disease/find-clinical-trials/

For information about clinical trials sponsored by private sources, contact:
http://www.centerwatch.com/

For information about clinical trials conducted in Europe, contact:
https://www.clinicaltrialsregister.eu/

  • < Sección anterior
  • Sección siguiente >
  • < Sección anterior
  • Sección siguiente >

Referencias

  1. Velasco D, Olney AH, Starr L. SLC25A24 Fontaine Progeroid Syndrome. 2022 Jun 9. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK581082/ Accessed March 27, 2025.
  2. Lally S, Walsh N, Kenny J, et al. Fontaine progeroid syndrome-A case report. Clin Case Rep. 2022;10(9):e6291. Published 2022 Sep 6. doi:10.1002/ccr3.6291
  3. Rodríguez-García ME, Cotrina-Vinagre FJ, Cruz-Rojo J, et al. A rare male patient with Fontaine progeroid syndrome caused by p.R217H de novo mutation in SLC25A24. Am J Med Genet A. 2018;176(11):2479-2486. doi:10.1002/ajmg.a.40496
  4. Legué J, François JHM, van Rijswijk CSP, van Brakel TJ. Is Gorlin-Chaudhry-Moss syndrome associated with aortopathy? Eur J Cardiothorac Surg. 2020;58(3):654-655. doi:10.1093/ejcts/ezaa108
  5. Fontaine progeroid syndrome. OMIM. 6/4/2020. https://omim.org/entry/612289 Accessed March 27, 2025.
  6. Writzl K, Maver A, Kovačič L, et al. De Novo Mutations in SLC25A24 Cause a Disorder Characterized by Early Aging, Bone Dysplasia, Characteristic Face, and Early Demise. Am J Hum Genet. 2017;101(5):844-855. doi:10.1016/j.ajhg.2017.09.017
  7. Ryu J, Ko JM, Shin CH. A 9-year-old Korean girl with Fontaine progeroid syndrome: a case report with further phenotypical delineation and description of clinical course during long-term follow-up. BMC Med Genet. 2019;20(1):188. Published 2019 Nov 27. doi:10.1186/s12881-019-0921-9
  8. Gorlin-Chaudhry-Moss syndrome. MedlinePlus. February, 2018. https://medlineplus.gov/genetics/condition/gorlin-chaudhry-moss-syndrome/ Accessed March 27, 2025.
  • < Sección anterior
  • Sección siguiente >

Programas & Recursos

RareCare logo in two lines.

Programas de asistencia RareCare®

Programas de Asistencia Adicional

Programa de Asistencia MedicAlert

NORD y la Fundación MedicAlert se han asociado en un nuevo programa para brindar protección a pacientes con enfermedades raras en situaciones de emergencia.

Aprende más https://rarediseases.org/patient-assistance-programs/medicalert-assistance-program/

Programa de Apoyo Educativo de Enfermedades Raras

Asegurarse de que los pacientes y los cuidadores estén equipados con las herramientas que necesitan para vivir su mejor vida mientras manejan su condición rara es una parte vital de la misión de NORD.

Aprende más https://rarediseases.org/patient-assistance-programs/rare-disease-educational-support/

Programa de descanso para cuidadores raros

Este programa de asistencia, primero en su tipo, está diseñado para los cuidadores de un niño o adulto diagnosticado con un trastorno raro.

Aprende más https://rarediseases.org/patient-assistance-programs/caregiver-respite/

Organizaciones de pacientes


More Information

The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.

GARD Disease Summary

The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).

View report
Orphanet

Orphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.

View report
OMIM

Online Mendelian Inheritance In Man (OMIM) has a summary of published research about this condition and includes references from the medical literature. The summary contains medical and scientific terms, so we encourage you to share and discuss this information with your doctor. OMIM is authored and edited at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine.

View report